These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 1899291)
1. Detection of human factor B biosynthesis in culture supernatants and cell lysates by ELISA. Mitani M; Good RA; Day NK Proc Soc Exp Biol Med; 1991 Feb; 196(2):188-93. PubMed ID: 1899291 [TBL] [Abstract][Full Text] [Related]
2. Biosynthesis of the third component of complement (C3) by the human monocytic-cell line U-937. Induction by phorbol myristate acetate. Bengio S; Gilbert D; Peulve P; Daveau M; Fontaine M Biochem J; 1986 Nov; 239(3):711-6. PubMed ID: 3827822 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta modulates C3 and factor B biosynthesis and complement receptor 3 expression in cultured human monocytes. Høgåsen AK; Hestdal K; Høgåsen K; Abrahamsen TG J Leukoc Biol; 1995 Feb; 57(2):287-96. PubMed ID: 7852844 [TBL] [Abstract][Full Text] [Related]
4. Expression of properdin in human monocytes. Schwaeble W; Huemer HP; Möst J; Dierich MP; Ströbel M; Claus C; Reid KB; Ziegler-Heitbrock HW Eur J Biochem; 1994 Feb; 219(3):759-64. PubMed ID: 8112326 [TBL] [Abstract][Full Text] [Related]
5. Lymphokine and phorbol (PMA) regulation of complement (C2) synthesis using U937. Littman BH; Hall RE; Muchmore AV Cell Immunol; 1983 Feb; 76(1):189-95. PubMed ID: 6831567 [TBL] [Abstract][Full Text] [Related]
6. Granulocyte-macrophage colony-stimulating factor, but not macrophage colony-stimulating factor, suppresses basal and lipopolysaccharide-stimulated complement factor production in human monocytes. Høgåsen AK; Hestdal K; Abrahamsen TG J Immunol; 1993 Sep; 151(6):3215-24. PubMed ID: 7690797 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of complement components C3 and factor B in human keratinocytes is differentially regulated by cytokines. Pasch MC; Van Den Bosch NH; Daha MR; Bos JD; Asghar SS J Invest Dermatol; 2000 Jan; 114(1):78-82. PubMed ID: 10620119 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of complement components (C3, C2, B and C1-inhibitor) and lysozyme by human monocytes and macrophages. Lappin D; Hamilton AD; Morrison L; Aref M; Whaley K J Clin Lab Immunol; 1986 Jul; 20(3):101-5. PubMed ID: 3638367 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of chondrocyte responses to a human interleukin 1-like factor. Arend WP; Joslin FG; Massoni RJ Clin Immunol Immunopathol; 1985 Sep; 36(3):358-70. PubMed ID: 2990784 [TBL] [Abstract][Full Text] [Related]
10. Production of nuclease activity in U937 cells by phorbol 12-myristate 13-acetate and lipopolysaccharide. Kwon HJ; Kim DS J Biochem Mol Biol; 2003 Sep; 36(5):520-3. PubMed ID: 14536038 [TBL] [Abstract][Full Text] [Related]
11. Failure to detect interleukin (IL)-3 mRNA or protein in human keratinocytes: antibodies to granulocyte macrophage-colony-stimulating factor or IL-6 (but not IL-3) neutralize "IL-3" bioactivity. Kondo S; Ciarletta A; Turner KJ; Sauder DN; McKenzie RC J Invest Dermatol; 1995 Mar; 104(3):335-9. PubMed ID: 7860997 [TBL] [Abstract][Full Text] [Related]
13. Role of protein kinase C activation in synthesis of complement components C2 and factor B in interferon-gamma-stimulated human fibroblasts, glioblastoma cell line A172 and monocytes. Watanabe I; Horiuchi T; Fujita S Biochem J; 1995 Jan; 305 ( Pt 2)(Pt 2):425-31. PubMed ID: 7832755 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of C1 inhibitor (C1-INA) by a human monocyte-like cell line, U937. Randazzo BP; Dattwyler RJ; Kaplan AP; Ghebrehiwet B J Immunol; 1985 Aug; 135(2):1313-9. PubMed ID: 4008925 [TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of the third component of complement by the human monocyte-like cell line, U-937. Minta JO; Isenman DE Mol Immunol; 1987 Oct; 24(10):1105-11. PubMed ID: 3316990 [TBL] [Abstract][Full Text] [Related]
16. Developmentally regulated effects of lipopolysaccharide on biosynthesis of the third component of complement and factor B in human fibroblasts and monocytes. Strunk RC; Fleischer JA; Katz Y; Cole FS Immunology; 1994 Jun; 82(2):314-20. PubMed ID: 7927503 [TBL] [Abstract][Full Text] [Related]
17. [Monoclonal antibody mNI-58 inducing morphological changes in a human monocyte-like cell line, U937, stimulated with phorbol myristate acetate (PMA)]. Ikewaki N Nihon Saikingaku Zasshi; 1995 Oct; 50(4):1033-7. PubMed ID: 8544343 [TBL] [Abstract][Full Text] [Related]
18. Induction of cytotoxic effector activity in the HL-60 promyelocytic cell line by incubation with phorbol myristate acetate: a model system of human spontaneous monocyte-mediated cytotoxicity. Hall RE; Muchmore AV; Decker JM; Blaese RM Cell Immunol; 1983 Feb; 76(1):58-68. PubMed ID: 6572566 [TBL] [Abstract][Full Text] [Related]
19. A novel monoclonal antibody mNI-58A against the alpha-chain of leukocyte function-associated antigen-1 (LFA-1) blocks the homotypic cell aggregation and actively regulates morphological changes in the phorbol myristate acetate (PMA)-activated human monocyte-like cell line, U937. Ikewaki N; Yamada A; Sonoda A; Inoko H Tissue Antigens; 1996 Sep; 48(3):161-73. PubMed ID: 8896174 [TBL] [Abstract][Full Text] [Related]
20. NRF2 Signaling Negatively Regulates Phorbol-12-Myristate-13-Acetate (PMA)-Induced Differentiation of Human Monocytic U937 Cells into Pro-Inflammatory Macrophages. Song MG; Ryoo IG; Choi HY; Choi BH; Kim ST; Heo TH; Lee JY; Park PH; Kwak MK PLoS One; 2015; 10(7):e0134235. PubMed ID: 26222138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]